Merck & Co. Inc. buy Barclays PLC
Start price
02.02.24
/
50%
€116.60
Target price
02.02.25
€134.11
Performance (%)
-8.13%
Price
16:05
€105.00
Summary
This prediction is currently active. With a performance of -8.13%, the BUY prediction for Merck & Co. Inc. by Barclays_PLC is down slightly. Dividends of €2.12 are taken into consideration when calculating the performance. This prediction currently runs until 02.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 0.768% | 0.768% |
iShares Core DAX® | 2.291% | 2.984% |
iShares Nasdaq 100 | 1.336% | -0.196% |
iShares Nikkei 225® | 1.132% | 2.488% |
iShares S&P 500 | 1.272% | 1.334% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $135.00 to $145.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat